vs

Side-by-side financial comparison of Corpay (CPAY) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Corpay is the larger business by last-quarter revenue ($1.2B vs $1.0B, roughly 1.2× Everus Construction Group, Inc.). Corpay runs the higher net margin — 21.2% vs 5.5%, a 15.7% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 20.7%). Corpay produced more free cash flow last quarter ($760.3M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 15.5%).

Corpay, Inc., headquartered in Atlanta, Georgia, provides payments and spend management systems and services that control expense-related purchasing and payment processes. The company focuses on vehicle-related expenses, lodging expenses, and corporate payments.

CPAY vs ECG — Head-to-Head

Bigger by revenue
CPAY
CPAY
1.2× larger
CPAY
$1.2B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+12.5% gap
ECG
33.2%
20.7%
CPAY
Higher net margin
CPAY
CPAY
15.7% more per $
CPAY
21.2%
5.5%
ECG
More free cash flow
CPAY
CPAY
$736.8M more FCF
CPAY
$760.3M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
15.5%
CPAY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPAY
CPAY
ECG
ECG
Revenue
$1.2B
$1.0B
Net Profit
$264.5M
$55.3M
Gross Margin
11.6%
Operating Margin
45.2%
6.8%
Net Margin
21.2%
5.5%
Revenue YoY
20.7%
33.2%
Net Profit YoY
7.5%
60.4%
EPS (diluted)
$3.74
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPAY
CPAY
ECG
ECG
Q4 25
$1.2B
$1.0B
Q3 25
$1.2B
$986.8M
Q2 25
$1.1B
$921.5M
Q1 25
$1.0B
$826.6M
Q4 24
$1.0B
$759.6M
Q3 24
$1.0B
$761.0M
Q2 24
$975.7M
$703.4M
Q1 24
$935.3M
$625.7M
Net Profit
CPAY
CPAY
ECG
ECG
Q4 25
$264.5M
$55.3M
Q3 25
$277.9M
$57.0M
Q2 25
$284.2M
$52.8M
Q1 25
$243.2M
$36.7M
Q4 24
$246.0M
$34.5M
Q3 24
$276.4M
$41.8M
Q2 24
$251.6M
$39.0M
Q1 24
$229.8M
$28.2M
Gross Margin
CPAY
CPAY
ECG
ECG
Q4 25
11.6%
Q3 25
12.6%
Q2 25
13.0%
Q1 25
11.2%
Q4 24
11.4%
Q3 24
11.8%
Q2 24
12.6%
Q1 24
11.9%
Operating Margin
CPAY
CPAY
ECG
ECG
Q4 25
45.2%
6.8%
Q3 25
44.6%
7.3%
Q2 25
43.5%
7.9%
Q1 25
42.5%
6.2%
Q4 24
47.2%
6.1%
Q3 24
45.5%
7.1%
Q2 24
44.4%
7.3%
Q1 24
42.5%
6.2%
Net Margin
CPAY
CPAY
ECG
ECG
Q4 25
21.2%
5.5%
Q3 25
23.7%
5.8%
Q2 25
25.8%
5.7%
Q1 25
24.2%
4.4%
Q4 24
23.8%
4.5%
Q3 24
26.9%
5.5%
Q2 24
25.8%
5.5%
Q1 24
24.6%
4.5%
EPS (diluted)
CPAY
CPAY
ECG
ECG
Q4 25
$3.74
$1.09
Q3 25
$3.91
$1.11
Q2 25
$3.98
$1.03
Q1 25
$3.40
$0.72
Q4 24
$3.43
$0.68
Q3 24
$3.90
$0.82
Q2 24
$3.52
$0.76
Q1 24
$3.12
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPAY
CPAY
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
$2.4B
Total DebtLower is stronger
$10.0B
$281.5M
Stockholders' EquityBook value
$3.9B
$629.8M
Total Assets
$26.4B
$1.7B
Debt / EquityLower = less leverage
2.58×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPAY
CPAY
ECG
ECG
Q4 25
$2.4B
Q3 25
$2.0B
Q2 25
$2.2B
Q1 25
$1.6B
Q4 24
$1.6B
Q3 24
$1.3B
$553.0K
Q2 24
$1.4B
Q1 24
$1.3B
Total Debt
CPAY
CPAY
ECG
ECG
Q4 25
$10.0B
$281.5M
Q3 25
$8.1B
$285.1M
Q2 25
$8.1B
$288.6M
Q1 25
$8.2B
$292.1M
Q4 24
$8.0B
$295.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CPAY
CPAY
ECG
ECG
Q4 25
$3.9B
$629.8M
Q3 25
$4.1B
$573.0M
Q2 25
$3.9B
$514.4M
Q1 25
$3.5B
$460.2M
Q4 24
$3.1B
$422.6M
Q3 24
$3.1B
$453.3M
Q2 24
$2.8B
$490.0M
Q1 24
$3.3B
$464.3M
Total Assets
CPAY
CPAY
ECG
ECG
Q4 25
$26.4B
$1.7B
Q3 25
$19.7B
$1.6B
Q2 25
$20.4B
$1.5B
Q1 25
$18.5B
$1.4B
Q4 24
$18.0B
$1.3B
Q3 24
$17.6B
$1.3B
Q2 24
$16.2B
Q1 24
$15.8B
Debt / Equity
CPAY
CPAY
ECG
ECG
Q4 25
2.58×
0.45×
Q3 25
1.99×
0.50×
Q2 25
2.07×
0.56×
Q1 25
2.37×
0.63×
Q4 24
2.56×
0.70×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPAY
CPAY
ECG
ECG
Operating Cash FlowLast quarter
$812.7M
$48.2M
Free Cash FlowOCF − Capex
$760.3M
$23.5M
FCF MarginFCF / Revenue
60.9%
2.3%
Capex IntensityCapex / Revenue
4.2%
2.4%
Cash ConversionOCF / Net Profit
3.07×
0.87×
TTM Free Cash FlowTrailing 4 quarters
$1.3B
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPAY
CPAY
ECG
ECG
Q4 25
$812.7M
$48.2M
Q3 25
$-378.9M
$76.2M
Q2 25
$1.1B
$25.3M
Q1 25
$-74.2M
$7.1M
Q4 24
$648.7M
Q3 24
$400.8M
$78.9M
Q2 24
$540.9M
Q1 24
$350.2M
$21.9M
Free Cash Flow
CPAY
CPAY
ECG
ECG
Q4 25
$760.3M
$23.5M
Q3 25
$-429.8M
$65.7M
Q2 25
$1.1B
$12.3M
Q1 25
$-118.9M
$-11.4M
Q4 24
$604.6M
Q3 24
$355.0M
$60.9M
Q2 24
$496.8M
Q1 24
$309.0M
$12.6M
FCF Margin
CPAY
CPAY
ECG
ECG
Q4 25
60.9%
2.3%
Q3 25
-36.7%
6.7%
Q2 25
98.7%
1.3%
Q1 25
-11.8%
-1.4%
Q4 24
58.4%
Q3 24
34.5%
8.0%
Q2 24
50.9%
Q1 24
33.0%
2.0%
Capex Intensity
CPAY
CPAY
ECG
ECG
Q4 25
4.2%
2.4%
Q3 25
4.3%
1.1%
Q2 25
4.8%
1.4%
Q1 25
4.5%
2.2%
Q4 24
4.3%
Q3 24
4.4%
2.4%
Q2 24
4.5%
Q1 24
4.4%
1.5%
Cash Conversion
CPAY
CPAY
ECG
ECG
Q4 25
3.07×
0.87×
Q3 25
-1.36×
1.34×
Q2 25
4.01×
0.48×
Q1 25
-0.30×
0.19×
Q4 24
2.64×
Q3 24
1.45×
1.89×
Q2 24
2.15×
Q1 24
1.52×
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPAY
CPAY

Vehicle Payments$572.9M46%
Corporate Payments$480.8M39%
Lodging Payments$112.5M9%
Other Operating Segments$82.1M7%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons